Business Wire

Mary Kay Inc. Names Tara Eustace Chief Opportunity and Sales Officer

Share

To empower future growth, iconic beauty and entrepreneurship company Mary Kay announced today the appointment of Tara Eustace as Chief Opportunity and Sales Officer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305002799/en/

To empower future growth, iconic beauty and entrepreneurship company Mary Kay announced today the appointment of Tara Eustace as Chief Opportunity and Sales Officer. As International Women's Day (IWD) approaches, this leadership appointment by the Chief Executive Officer, Ryan Rogers, honors Mary Kay Ash’s legacy of empowering women. A trailblazer and long-time Mary Kay executive, Eustace will lead the Global Opportunity and Sales organization with a core mission: to put the “Mary Kay Opportunity” at the center of all entrepreneurial business strategies. She will oversee all Mary Kay regions, leading the team of region presidents and general managers in over 40 markets around the world (Photo: Mary Kay Inc.).

A trailblazer and long-time Mary Kay executive, Eustace will lead the Global Opportunity and Sales organization with a core mission: to put the “Mary Kay Opportunity” at the center of all entrepreneurial business strategies. She will oversee all Mary Kay regions, leading the team of region presidents and general managers in over 40 markets around the world.

Eustace’s newly formed organization will focus on transforming the Independent Beauty Consultant (IBC) experience, elevating them as personal beauty advisors for Mary Kay’s product portfolio, brand, and opportunity. With the core mission at the forefront, Eustace will be inviting the next generation to join the entrepreneurial journey. To achieve the vision, she and her team will digitally empower all generations of IBCs with every opportunity to connect their businesses with consumers through digital upskilling, innovative digital tools, and e-commerce solutions across integrated platforms and channels.

Eustace will drive the streamlining of global sales operations, activating four strategic areas: global salesforce development and education, global salesforce experience, global salesforce insights & analytics, and global salesforce social commerce and communications. This includes a commitment to expanding Mary Kay’s footprint to empower women to pursue the dream of owning their small businesses wherever they are.

“Tara and her team are on a mission to ignite passion around the Mary Kay Opportunity, putting it at the forefront of everything we do,” said Ryan Rogers, Chief Executive Officer (CEO) of Mary Kay. “With her entrepreneurial and visionary mindset and a track record of breaking into new markets, Tara will be instrumental in shaping the future of the business for our Independent Beauty Consultants and their customers, leveraging technology and elevating our unparalleled experience to new heights in the beauty and direct-selling industries.”

Eustace has served in various leadership positions worldwide over the course of her more than thirty-year career. Her unwavering commitment to women’s entrepreneurship has contributed to reshaping the direct selling industry, touching the lives of millions of women, from personal growth to financial rewards and more. Eustace has led Mary Kay's growth in Europe and beyond, spearheading the most recent Mary Kay expansions into Hungary in 2023 and Kyrgyzstan in 2024.

“When Mary Kay Ash founded our company, she knew that no greater opportunity existed for women than the one we have to offer. I am energized to ignite innovation, empower our Independent Beauty Consultants to sell with confidence wherever they are, and connect the next generation to a vibrant, sustainable, and dynamic earning opportunity,” said Tara Eustace, Mary Kay’s Chief Opportunity and Sales Officer. “Every single one of our Independent Beauty Consultants is a small business owner who directly benefits from the sale of Mary Kay products. When local customers purchase Mary Kay products from Independent Beauty Consultants, they support a family. And when they support a family, they support a dream.”

Eustace holds a Bachelor of Arts degree in Russian Studies and International Relations from the University of Virginia, United States. She serves on the European Direct Selling Association’s (Seldia) CEO Council Board.

As International Women's Day (IWD) approaches, this leadership appointment by Ryan Rogers honors Mary Kay Ash’s legacy of empowering women. At Mary Kay, women make up 54% of the executive team, 63% of the global workforce, and 63% of the R&D team1.

Did you know:

  • Nearly 30% of sales force members who started a Mary Kay business over the past year are under the age of 352.
  • In 2023 and again in 2024, Mary Kay was named the #1 Direct Selling Brand of Skin Care & Color Cosmetics in the world by Euromonitor International3.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 40 markets. For over 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on X.

______________________________

1 Source: Women Representation and Leadership at Mary Kay (May 2024)

2 Source: Mary Kay Inc. 2024 U.S. data

3 “Source Euromonitor International Limited; Beauty and Personal Care 2024 Edition, value sales at RSP, 2023 data”

View source version on businesswire.com: https://www.businesswire.com/news/home/20250305002799/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Rimini Street Announces Upcoming 2025 Investor Conference Schedule15.5.2025 22:51:00 CEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that Michael L. Perica, chief financial officer, and Dean Pohl, vice president, treasurer and investor relations, will be presenting and meeting with investors one-on-one and in small group meetings at the following conferences: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515374696/en/ Rimini Street Announces Upcoming 2025 Investor Conference Schedule May 28, 2025: Craig-Hallum 22nd Annual Institutional Investor Conference, Minneapolis May 29, 2025: TD Cowen 53rd Annual TMT Conference, New York City Fireside Chat: 1:15 pm Eastern, webcast link June 24-26, 2025: Roth 15th Annual London Conference, London To schedule a meeting please contact your salesperson or Rimini Street Investor Relations at IR@rimin

Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States15.5.2025 20:30:00 CEST | Press release

Zynyz® (retifanlimab-dlwr), a PD-1 inhibitor, is now approved for the treatment of advanced squamous cell carcinoma of the anal canal (SCAC) in combination with chemotherapy and as a monotherapyPatients with SCAC treated with Zynyz achieved a statistically significant improvement in progression-free survival and improvement in overall survival Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz® (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for the treatment of adult patients with locally recurrent or with metastatic SCAC with disease progression on or intolerance to platinum-based chemotherapy. Thi

DDC Announces Record 2024 Growth and Strategic Bitcoin Reserve Initiative in Shareholder Letter by Founder & CEO Norma Chu15.5.2025 20:23:00 CEST | Press release

DDC Enterprise Ltd. (NYSEAM: DDC), today released its 2024 full year results alongside a Shareholder Letter from Founder, Chairwoman, and CEO Norma Chu, underscoring the company’s positive financial performance and unveiling a pioneering Bitcoin accumulation strategy poised to redefine long-term value creation. To Our Valued Shareholders, 2024 was a year of transformative growth and strategic milestones for DDC. I am thrilled to share that we not only met our financial forecasts but exceeded expectations, delivering strong performance across key metrics while laying the groundwork for an even more exciting future. As we enter 2025, our momentum is accelerating, driven by disciplined execution and a bold new chapter in our corporate strategy. 2024 Financial & Operational HighlightsRevenue Growth: USD 37.4 million, a 33% year-over-year increase, propelled by the strategic acquisition of U.S. brands and sustained resilience in our core China operations. Margin Expansion: Gross profit marg

Ras Al Khaimah’s Strong Economic and Investment Environment Validated by Fitch Affirmation of ‘A+’ Credit Rating, With Stable Outlook15.5.2025 20:18:00 CEST | Press release

The positive rating reflects the Emirate’s strong long-term growth prospects and ongoing economic diversification Ras Al Khaimah’s strategic approach to sustainable, cross-sector growth and strong economic and investment environment has been validated by international credit rating agency Fitch, which reaffirmed the rating at ‘A+’ with a stable outlook. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515907689/en/ Ras Al Khaimah’s strong economic and investment environment validated by Fitch affirmation of ‘A+’ credit rating, with Stable Outlook (Photo: AETOSWire) Ras Al Khaimah Government welcomed the announcement as an endorsement of the Emirate’s resilient and expanding economy, sound fiscal management and the clear vision and unwavering commitment of its leadership to sustainable, long-term development and growth. The Emirate’s landmark tourism projects, including a major integrated resort, luxury hotels and world-clas

Cessna Citation CJ4 Gen3 Flight Test Program Advances Through Milestones as Second Test Article Takes Flight15.5.2025 20:00:00 CEST | Press release

Textron Aviation today announced a major program milestone for the Cessna Citation CJ4 Gen3 flight test program with the successful first flight of a second test article — P1. Testing on the P1 aircraft will focus on avionics, human factors and interiors. The Citation CJ4 Gen3 business jet is designed to keep pilots a step ahead in the cockpit by offering the next-generation Garmin G3000 PRIME avionics along with the most standard features in its class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515438856/en/ Cessna Citation CJ4 Gen3 flight test program advances through milestones as second test article takes flight. (Photo Credit: Textron Aviation) The Cessna Citation CJ4 Gen3 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. “This achievement continues the forward momentum of the CJ4 Gen3 program and reflects the dedication and expertise of our team in designing, certifying an

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye